Evofem Biosciences, Inc. Quarterly Operating Margin in % from Q4 2020 to Q4 2022

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Evofem Biosciences, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q4 2022.
  • Evofem Biosciences, Inc. Operating Margin for the quarter ending December 31, 2022 was -500 %, a 75.3% increase year-over-year.
  • Evofem Biosciences, Inc. annual Operating Margin for 2022 was -500 %, a 75.3% increase from 2021.
  • Evofem Biosciences, Inc. annual Operating Margin for 2021 was -2.02K %, a 91.3% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2022 -500 +1.52K +75.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 -541 +2.87K +84.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -862 +3.48K +80.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 -1.32K +7.01K +84.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 -2.02K +21.2K +91.3% Oct 1, 2021 Dec 31, 2021
Q3 2021 -3.41K Jul 1, 2021 Sep 30, 2021
Q2 2021 -4.34K Apr 1, 2021 Jun 30, 2021
Q1 2021 -8.33K Jan 1, 2021 Mar 31, 2021
Q4 2020 -23.2K Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.